Choose a section
GlaxoSmithKline and Amicus Therapeutics have started a late-stage clinical trial for a drug to treat a rare genetic disorder, the companies said.
GlaxoSmithKline is making a donation that it said would give more than 10,000 girls and women access to human papillomavirus vaccination.
Drug maker Eli Lilly is investing $30 million in a partnership that will address noncommunicable diseases, also known as chronic diseases.
Attacks on a human papillomavirus vaccine made amid an increasingly caustic Republican presidential primary battle have drawn a response from the manufacturer.
Singer and atrial fibrillation patient Barry Manilow has joined Sanofi's national education campaign designed to raise awareness about atrial fibrillation.
An insulin analogue made by Sanofi appears to work better in certain cases than competing treatments at reducing weight gain and controlling blood sugar among patients with Type 2 diabetes.
The Food and Drug Administration is reorganizing its division for regulating cancer drugs, the agency said Monday.
Patients treated with a long-acting drug for Type 2 diabetes experienced a reduction in cardiovascular health risk factors, according to results of a study presented at the European Association for the Study of Diabetes' annual meeting.
Genentech has applied for Food and Drug Administration approval of a drug for treating skin cancer, the drug maker said Monday.
While it has been a boon to elderly Americans, Medicare Part D includes a complicating factor that has proven to be a headache.